Chinese Journal of Pharmaceuticals
|
2023, 54(6): 957-964
• Pharmaceutical Management & Information •
Status and Analysis of Domestic and Foreign Laws and Regulations on Accelerated CMC Development and Registration of Innovative Therapeutic Biological Products
Full
Xianglin LYU
1, Yaying WANG
2, Xiaohua ZHANG
2, Ming CHEN
2, Linqi ZHANG
1
Affiliations
- 1.School of Medicine, Tsinghua University, Beijing 100084
- 2.GlaxoSmithKline Company, Beijing 100025
Published: 2023-06-10
doi: 10.16522/j.cnki.cjph.2023.06.018
Outline
吕香霖, 王雅英, 张小华, 陈明, 张林琦.
加速创新型治疗用生物制品CMC开发与注册的国内外法规现状与分析.
中国医药工业杂志,
2023
, 54
(6)
: 957
-964
.
DOI: 10.16522/j.cnki.cjph.2023.06.018
Xianglin LYU, Yaying WANG, Xiaohua ZHANG, Ming CHEN, Linqi ZHANG.
Status and Analysis of Domestic and Foreign Laws and Regulations on Accelerated CMC Development and Registration of Innovative Therapeutic Biological Products[J].
Chinese Journal of Pharmaceuticals,
2023
, 54
(6)
: 957
-964
.
DOI: 10.16522/j.cnki.cjph.2023.06.018
Year 2023 volume 54 Issue 6
28
8
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2023.06.018
- Receive Date:2022-09-20
- Online Date:2026-11-19
- Published:2023-06-10